Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
ABVC BioPharma, Inc. (ABVC) had Income from Continuous Operations of $-1.69M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-1.56M |
|
-- |
|
-- |
|
$1.57M |
|
$-1.57M |
|
$-0.12M |
|
$-1.69M |
|
$-1.66M |
|
$-1.69M |
|
|
Income from Continuous Operations |
$-1.69M |
$-1.69M |
|
$-1.66M |
|
$-1.57M |
|
$-1.48M |
|
25.45M |
|
25.45M |
|
$-0.06 |
|
$-0.06 |
|
| Balance Sheet Financials | |
$0.65M |
|
$12.82M |
|
$19.08M |
|
$19.73M |
|
$5.39M |
|
-- |
|
$1.51M |
|
$6.90M |
|
$12.83M |
|
$12.83M |
|
$12.83M |
|
25.04M |
|
| Cash Flow Statement Financials | |
$-0.89M |
|
$0.05M |
|
$-0.34M |
|
$1.33M |
|
$0.14M |
|
$-1.19M |
|
$0.79M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.12 |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.89M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-13.17% |
|
-13.17% |
|
-8.56% |
|
-13.17% |
|
$0.51 |
|
$-0.04 |
|
$-0.04 |
|